CPHI Frankfurt, 2022!
Meet our team at stand 80C71
November 1st to 3rd, 2022
Messe Frankfurt, Germany
The Aurigene expertise
Aurigene Pharmaceutical Services is a leading contract research, development and manufacturing organization (CDMO) that provides a range of services. Built on the legacy of accelerating innovation and backed by a vast experience in integrated drug discovery, development and manufacturing services, we provide access to our knowledge, resources, capability and experience, creating shared success for our clients and ultimately patients.
About CPHI Worldwide
Founded in 1890, the Drug, Chemical & Associated Technologies Association, Inc. (DCAT) is a not-for-profit, corporate member-supported, and volunteer-led global business development association for companies engaged in the Bio/Pharmaceutical manufacturing value chain.
For over 130 years, DCAT has been providing a lifelong collegial community for its member companies and their representatives. DCAT facilitates the development of relationships within its unique member company profile, which spans the whole manufacturing value chain of the Bio/Pharmaceutical industry.
DCAT develops objective, expert-driven education programmes and informational services that help its member companies in getting quick insights into industry market trends, best practices, and industry-related concerns.
Why Aurigene Pharmaceutical Services?
Infrastructure 8 US FDA plants, 2 R&D centers and AAALAC animal vivarium
One Stop Shop Discovery to manufacturing
Science Strong technology platforms with niche/ sensitive/ complex chemistry expertise
Digitally Enabled Systems ELN, e-BPRs, MES, SAP etc. are fully enabled at R&D/cGMP site
ESG Commitment to highest standards of Environment, Social and Governance
Meet our Experts
Akhil Ravi
CEO
Baburaj Krishnan
Head CDMO (DS)
Ganesh Vaidyanathan
Head, Business Development
Olivier Langrene
Head, Europe Business Development
Paul Bradley
Sr. Director, Business Development
Daniel Heinrich
Director, Business Development
PVR Bharadwaja
Head - Presales, Marketing and Strategy
Services we Offer
Chemical Development Services
Aurigene Pharmaceutical Services provides a wide range of pharmaceutical drug development services for pre-clinical and clinical trials I, II and III wherein we synthesize New Chemical Entity (NCE) from few grams for efficacy and toxicology studies to multi-kilogram for clinical trial studies. These can be offered from GLP compliant and cGMP environment to meet client requirements.
Formulation Development Services
Aurigene Pharmaceutical Services offers end-to-end formulation development services ranging from early development to clinical supplies for new chemical entities for the pharmaceutical, nutraceutical & animal healthcare industry along with life cycle extension of the products. We have the expertise along with the state-of-the-art infrastructure and diverse experience to develop formulations for your pre-clinical and clinical needs to support oral, topical & parenteral administration. Our formulation development effort revolves around developing the best formulation for your compound, focusing on the desired bioavailability and optimal stability of your drug product.
Starting with comprehensive pre-formulation services Aurigene Pharmaceutical Services helps its clients to determine optimal dosage forms they can use for pre-clinical or clinical applications.
Manufacturing Services
Aurigene has access to the manufacturing facilities of Dr. Reddy’s and a network of strategic business partners. Our pharmaceutical drug manufacturing services offer a wide range of manufacturing services from a few kilos to multi tons of cGMP manufacturing of Key Starting Material (KSM) / Registered Starting Materials (RSM), advanced intermediates, APIs and finished formulations. We have manufacturing options across the globe, with our facilities located in India, the UK, Mexico and the US. With a strong legacy of supporting New Chemical Entity (NCE) manufacturing, drug substances and drug products commercial manufacturing, we are able to cater to Pharma, Specialty, Nutraceutical and Animal Health companies.
CDMO Facility Locations
INDIA
Aurigene Discovery Technologies Limited
39-40, KIADB Industrial Area, Electronic City Phase - II, Hosur Road, Bangalore - 560100, Karnataka, India.
INDIA
Aurigene Discovery Technologies Limited
39-40 Hosur Road KIADB Industrial Area, Joggers Ln, Electronic City Phase II, Electronic City, Bengaluru, Karnataka 560100
UK: API/ RSM Manufacturing Plant
Aurigene Pharmaceutical Services | CDMO
Steanard Ln, Mirfield W14 8HZ, United Kingdom
Mexico: API/ mPEG Alcohol Manufacturing Plant
Aurigene Pharmaceutical Services | CDMO
C.P, Carretera Federal Cuernavaca-Cuautla Km. 4.5 Colonia CIVAC Jiutepec, 62578 Cuernavaca, Mor., Mexico
You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.
If you wish to continue to this external website, click Proceed.
Leaving already?
Don't forget to join us at
CPHI Worldwide 2023.
October 24th-26th, 2023 | Barcelona, Spain
Get ready to accelerate your drug’s journey to the market